Allergan, Mohawk Tribe Ask for Supreme Court Review of Scrutinized Patent Case

Source: BioPharma Dive


Allergan and the St. Regis Mohawk Tribe aim to continue their legal battle in defense of a controversial patent agreement struck a little over a year ago, appealing last week to the Supreme Court to review a federal appeals court decision which had undermined the deal’s main rationale, according to a BioPharma Dive report.

Last July, the U.S. Court of Appeals for the Federal Court ruled the St. Regis Mohawk Tribe couldn’t claim tribal sovereign immunity to sidestep certain patent challenges from would-be generic rivals to Allergan’s dry eye drug Restasis. Allergan had previously handed the tribe rights to the top-selling medicine in a highly unusual legal maneuver designed to shield the top-selling drug from competition.

Read the full article.


Related Content